COMPANY DESCRIPTION
Employees: 1-10
Investment Type: Venture Capital
Portfolio 15
Date | Name | Website | Total Raised | Location |
- | Horizon Ph... | horizonpha... | $370K | United Sta... |
- | Intact Vas... | intactvasc... | $145.5M | United Sta... |
- | Achillion ... | achillion.... | - | United Sta... |
- | Melinta Th... | melinta.co... | $137M | United Sta... |
- | TELA Bio | telabio.co... | $71.3M | United Sta... |
- | TearScienc... | tearscienc... | $129.5M | United Sta... |
- | NYDHA | digitalhea... | - | - |
- | Rapid Micr... | rapidmicro... | $293.6M | United Sta... |
- | Insmed | insmed.com | - | United Sta... |
- | Vesper Med... | vespermedi... | $37M | United Sta... |
Show more
Mentions in press and media 15
Date | Title | Description | Source |
12.02.2018 | Philly healthcare and life science investment firm 1315 Capi... | Among its portfolio companies are Geneoptix, an oncology molecular diagnostics business; Innovative ... | medcitynew... |
15.06.2016 | PE firm 1315 Capital raises $200M fund to invest in health t... | What specific health technology trends spark your interest? We believe there is a significant opport... | medcitynew... |
14.05.2015 | Intact Vascular Raises $38.9M in Series B VC Financing | Intact Vascular, Inc., a Wayne, Pa.-based developer of medical devices for minimally invasive periph... | finsmes.co... |
15.04.2014 | Rapid Micro Biosystems Closes Additional Funding | Rapid Micro Biosystems, a Bedford, MA-based provider of automated, non-destructive, rapid microbial ... | finsmes.co... |
29.06.2013 | Rapid Micro Biosystems Raises $32.6M in Series B Financing | Rapid Micro Biosystems, a Bedford, MA-based provider of microbial detection for quality control test... | finsmes.co... |
25.10.2012 | VC prediction: 2013 will be a good year for medtech deals | Adele Olivia of Quaker Partners was also optimistic and said the quality and opportunity of deals is... | medcitynew... |
05.09.2012 | Intact Vascular Closes $15.5M Series A Financing | Intact Vascular, Inc., a Wayne, PA-based developer of medical devices for minimally invasive periphe... | finsmes.co... |
29.06.2012 | Reaction to the Obamacare ruling: Investors | “The forces set in motion by the act are inevitable and must be systematically addressed in any even... | medcitynew... |
16.03.2012 | Tarsa Therapeutics Closes $28M Series B Equity Financing | Tarsa Therapeutics, Inc., a Philadelphia, PA-based developer of a novel oral formulation of calciton... | finsmes.co... |
- | Reaction to the Obamacare ruling: Investors | Everyone — almost every one — had something to say about yesterday’s U.S. Supreme Court ruling that ... | medcitynew... |
Show more